Novel Paracrine Action of Endothelium Enhances Glucose Uptake in Muscle and Fat.

Adipose Tissue / metabolism Animals Cells, Cultured Diabetes Mellitus, Type 2 / metabolism Endothelium, Vascular / metabolism Glucose / metabolism Humans Hydrogen Peroxide / metabolism Insulin / metabolism Insulin-Like Growth Factor I / metabolism Mice Mice, Inbred C57BL MicroRNAs / genetics Muscle, Skeletal / metabolism NADPH Oxidase 4 / genetics Paracrine Communication Receptor, IGF Type 1 / genetics
catalase endothelium fasting glucose insulin microRNAs muscles

Journal

Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103

Informations de publication

Date de publication:
17 09 2021
Historique:
pubmed: 24 8 2021
medline: 11 1 2022
entrez: 23 8 2021
Statut: ppublish

Résumé

[Figure: see text].

Identifiants

DOI: 10.1161/CIRCRESAHA.121.319517 PMID: 34420367 PMC: PMC8448413
pubmed: 34420367
doi: 10.1161/CIRCRESAHA.121.319517
pmc: PMC8448413
mid: EMS133242
doi:

Substances chimiques

Igf1r protein, mouse 0
Insulin 0
MIRN25 microRNA, mouse 0
MicroRNAs 0
Insulin-Like Growth Factor I 67763-96-6
Hydrogen Peroxide BBX060AN9V
NADPH Oxidase 4 EC 1.6.3.-
Nox4 protein, mouse EC 1.6.3.-
Receptor, IGF Type 1 EC 2.7.10.1
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

720-734

Subventions

Organisme : British Heart Foundation
ID : RG/15/7/31521
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/14/10/30472
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/17/16/32853
Pays : United Kingdom
Organisme : British Heart Foundation
ID : 110044/Z/15/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1999001/11735
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/13/1/30086
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/06/115/21104
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/12/80/29821
Pays : United Kingdom

Références

J Biol Chem. 2011 Apr 15;286(15):13304-13
pubmed: 21343298
Diabetes. 2005 Feb;54(2):311-21
pubmed: 15677487
J Mol Cell Cardiol. 2013 Sep;62:111-21
pubmed: 23722270
Cell. 2013 Feb 14;152(4):673-84
pubmed: 23415219
Cell Metab. 2010 May 5;11(5):379-89
pubmed: 20444418
Cell Metab. 2011 Sep 7;14(3):390-402
pubmed: 21907144
Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1987-94
pubmed: 26160956
Antioxid Redox Signal. 2005 Jul-Aug;7(7-8):1021-31
pubmed: 15998257
Diabetes. 2017 Nov;66(11):2808-2821
pubmed: 28830894
Exp Eye Res. 1983 Feb;36(2):269-77
pubmed: 6337860
Endocrinology. 2009 Oct;150(10):4575-82
pubmed: 19608653
Diab Vasc Dis Res. 2019 Mar;16(2):160-170
pubmed: 30295509
J Clin Invest. 1983 Apr;71(4):974-9
pubmed: 6339562
J Biol Chem. 1993 Feb 5;268(4):2655-61
pubmed: 7679099
Diabetes. 2008 Dec;57(12):3307-14
pubmed: 18835939
Diabetes. 2005 Apr;54(4):1082-9
pubmed: 15793247
Mol Cell Biol. 2004 Mar;24(5):1844-54
pubmed: 14966267
EMBO J. 2016 Feb 1;35(3):319-34
pubmed: 26742780
Endocrinology. 2011 Mar;152(3):912-21
pubmed: 21239445
Nature. 1999 Jun 10;399(6736):601-5
pubmed: 10376603
Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2319-24
pubmed: 17717289
Microvasc Res. 1988 Mar;35(2):153-66
pubmed: 3285141
Sci Rep. 2016 Dec 12;6:38789
pubmed: 27941951
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):295-307
pubmed: 26715682
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1347-54
pubmed: 18467643
Diabetologia. 2017 Jun;60(6):1066-1075
pubmed: 28352940
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10162-7
pubmed: 21646544
Genes Dev. 2001 Aug 1;15(15):1926-34
pubmed: 11485987
J Immunol. 2007 Jun 1;178(11):7405-11
pubmed: 17513791
J Cell Biol. 2011 Jul 11;194(1):7-15
pubmed: 21746850
J Biol Chem. 2001 Jun 15;276(24):21938-42
pubmed: 11297536
Circ Res. 2012 Apr 27;110(9):1217-25
pubmed: 22456182
Diabetes. 2007 Feb;56(2):285-94
pubmed: 17259371
JCI Insight. 2017 Dec 21;2(24):
pubmed: 29263294
Acta Physiol (Oxf). 2017 Feb;219(2):346-361
pubmed: 27009502
J Biol Chem. 1994 Dec 23;269(51):32558-64
pubmed: 7798258
J Clin Invest. 2000 Dec;106(12):1521-30
pubmed: 11120759
Circ Res. 2017 Mar 3;120(5):784-798
pubmed: 27920123
Am J Nephrol. 2010;32(6):581-9
pubmed: 21071935
Cell Metab. 2011 Mar 2;13(3):294-307
pubmed: 21356519
J Clin Invest. 2003 May;111(9):1373-80
pubmed: 12727929
Nat Rev Mol Cell Biol. 2006 Feb;7(2):85-96
pubmed: 16493415
Physiol Genomics. 2000 Mar 13;2(2):77-83
pubmed: 11015585
Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1383-91
pubmed: 22492090
Eur J Clin Invest. 2007 Aug;37(8):643-50
pubmed: 17635575
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Biochim Biophys Acta. 1991 Nov 18;1070(1):1-10
pubmed: 1751515
J Cardiovasc Pharmacol Ther. 1998 Apr;3(2):125-134
pubmed: 10684490
Cell Metab. 2009 Oct;10(4):260-72
pubmed: 19808019
Physiol Rep. 2017 Nov;5(20):
pubmed: 29084841
Diabetes. 2013 Jun;62(6):2130-4
pubmed: 23349484
Nat Rev Drug Discov. 2011 Jun;10(6):453-71
pubmed: 21629295
Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):2041-7
pubmed: 12893685
Nat Rev Immunol. 2004 Mar;4(3):181-9
pubmed: 15039755
Metabolism. 1988 Aug;37(8):714-20
pubmed: 3043144
Cell. 1998 Oct 16;95(2):199-210
pubmed: 9790527
Nature. 1999 Jun 10;399(6736):597-601
pubmed: 10376602
Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1368-76
pubmed: 21415386
Front Physiol. 2012 Nov 01;3:412
pubmed: 23125837

Auteurs

Hema Viswambharan (H)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0002-7616-5026

Nadira Y Yuldasheva (NY)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0001-6213-6358

Helen Imrie (H)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Katherine Bridge (K)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0003-0495-9465

Natalie J Haywood (NJ)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0002-8762-7257

Anna Skromna (A)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0002-4937-8675

Karen E Hemmings (KE)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Emily R Clark (ER)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

V Kate Gatenby (VK)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Paul Cordell (P)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Katie J Simmons (KJ)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0003-4846-9097

Natallia Makava (N)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0001-8755-3369

Yilizila Abudushalamu (Y)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Naima Endesh (N)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Jane Brown (J)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Andrew M N Walker (AMN)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0003-0380-7283

Simon T Futers (ST)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Karen E Porter (KE)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0002-6442-7420

Richard M Cubbon (RM)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0001-7844-3600

Khalid Naseem (K)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Ajay M Shah (AM)

British Heart Foundation Centre of Research Excellence, King's College London (A.M.S.).
ORCID: 0000-0002-6547-0631

David J Beech (DJ)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Stephen B Wheatcroft (SB)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).

Mark T Kearney (MT)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0002-9376-8814

Piruthivi Sukumar (P)

Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.V., N.Y.Y., H.I., K.B., N.J.H., A.S., K.E.H., E.R.C., V.K.G., P.C., K.J.S., N.M., Y.A., N.E., J.B., A.M.N.W., S.T.F., K.E.P., R.M.C., K.N., D.J.B., S.B.W., M.T.K., P.S.).
ORCID: 0000-0002-3294-989X

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Tissus › Tissu conjonctif › Tissu adipeux › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Eucaryotes › Animaux › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Cellules › Cellules cultivées › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Maladies endocriniennes › Diabète › Diabète de type 2 › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Tissus › Épithélium › Endothélium › Endothélium vasculaire › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Glucides › Sucres › Oses › Hexose › Glucose › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Composés chimiques organiques › Radicaux libres › Peroxydes › Peroxyde d'hydrogène › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Hormones peptidiques › Hormones pancréatiques › Insulines › Insuline › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Somatomédines › Facteur de croissance IGF-I › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée C57BL › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN non traduit › Petit ARN non traduit › microARN › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Tissus › Muscles › Muscle strié › Muscles squelettiques › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › NADPH oxidase › NADPH Oxidase 4 › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Communication cellulaire › Communication paracrine › Novel Paracrine Action of Endothelium Enhances...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur facteur croissance › Récepteurs des somatomédines › Récepteur IGF de type 1 › Novel Paracrine Action of Endothelium Enhances...